$BFRGW News
Last published 2w ago
- 2w agoBFRGBFRGWBullFrog AI Founder and CEO Vin Singh to Deliver Keynote at AIDDD SummitGlobeNewswireGAITHERSBURG, Md., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI"), an AI company using its proprietary platform to turn complex biomedical data into
- 4w agoBFRGBFRGWBullFrog AI to Present at the 20th Annual LD Micro Main Event on October 20, 2026GlobeNewswireGAITHERSBURG, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), an AI company using its proprietary platform to turn complex
- 2mo agoBFRGBFRGWBullFrog AI to Participate in September 2026 Investor ConferencesGlobeNewswireGAITHERSBURG, Md., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn
- 3mo agoBFRGBFRGWBullFrog AI to Participate in the BTIG Virtual Biotechnology ConferenceGlobeNewswireGAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn
- 3mo agoBFRGBFRGWBullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026GlobeNewswireGAITHERSBURG, Md., July 21, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn
- 5mo agoBFRGBFRGWBullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI PlatformGlobeNewswireGAITHERSBURG, Md., June 02, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and
- 6mo agoBFRGBFRGWBullFrog AI Regains Compliance with Nasdaq Shareholders' Equity RequirementGlobeNewswireGAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and
- 7mo agoBFRGBFRGWBullFrog AI Announces Participation at AACR Annual MeetingGlobeNewswireGAITHERSBURG, Md., April 14, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and
- 7mo agoBFRGBFRGWBullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology PartnersGlobeNewswireGAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine
- 7mo agoBFRGBFRGWBullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive DisorderGlobeNewswireCommercial agreement serves as high-profile third party validation of BullFrog AI's proprietary capabilities Agreement utilizes BullFrog AI's end-to-end analytical AI platform to accelerate drug discovery and development
- 7mo agoBFRGBFRGWBullFrog AI Unveils bfARENAS™ Scenario-based Decision EngineGlobeNewswireGAITHERSBURG, Md., March 25, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and
- 9mo agoBFRGBFRGWBullFrog AI to Unveil New Precision AI CapabilityGlobeNewswireNew capabilities to be launched on March 25Unique technology bolsters BullFrog AI's end-to-end AI intelligence workflow with a scenario-based decision engineAdvances current AI decision tools by clearly defining clinical
- 9mo agoBFRGBFRGWBullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life SciencesGlobeNewswireGAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and
- 10mo agoBFRGBFRGWBullFrog AI Publishes Annual Letter to ShareholdersGlobeNewswireGAITHERSBURG, Md., Dec. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 11mo agoBFRGBFRGWBullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable InsightsGlobeNewswireGAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 12mo agoBFRGBFRGWBullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025GlobeNewswireGAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI Announces Abstract Accepted for Presentation at 2026 ASCO Gastrointestinal Cancers SymposiumGlobeNewswireAI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, submitted in collaboration with Eleison Pharmaceuticals, provides further
- 1y agoBFRGBFRGWJoin BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on October 30GlobeNewswireGAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ ModuleGlobeNewswireGAITHERSBURG, Md., Sept. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI and Sygnature Discovery Announce Official Sales Launch of BullFrog Data Networks™ to Global Biopharma ClientsGlobeNewswireGAITHERSBURG, Md., Sept. 25, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks WebinarGlobeNewswireGAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI's bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals CollaborationGlobeNewswireJoint oncology conference submission planned and follow-on contract discussion underway Validates BullFrog AI's enterprise-grade platform strategy, combining automation and human-in-the-loop oversight for scalable,
- 1y agoBFRGBFRGWBullFrog AI to Present at BTIG Annual Virtual Biotechnology ConferenceGlobeNewswireGAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWRethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug DevelopmentGlobeNewswireFrom target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI's bfLEAP™
- 1y agoBFRGBFRGWJoin BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on July 23GlobeNewswireGAITHERSBURG, Md., July 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI Launches bfPREP, a New AI-Powered Data Preparation Module in Its BullFrog Data Networks Solutions LibraryGlobeNewswireNew module addresses multi-billion-dollar data quality challenge in life sciences by automating data cleansing, standardization, and transformation for AI readiness Built for scale, security, and human in the loop
- 1y agoBFRGBFRGWBullFrog AI Unveils BullFrog Data Networks™ Solutions Library, Expanding Scalable AI-Powered Biomedical Insight Platform to Large EnterprisesGlobeNewswireNew Data Networks Solutions Library includes native deployment support across Google Cloud Platform, Microsoft Azure, and Amazon Web Services Built for scale, security, and domain expertise, the enterprise-wide solution
- 1y agoBFRGBFRGWBullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks WebinarGlobeNewswireGAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma ClientsGlobeNewswireGAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWJoin Bullfrog AI's Exclusive Live Investor Webinar and Q&A Session on April 23GlobeNewswireGAITHERSBURG, Md., April 17, 2025 (GLOBE NEWSWIRE) -- Bullfrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 TrialGlobeNewswireGAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI)
- 1y agoBFRGBFRGWBullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan WeekGlobeNewswireGAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI Issues Letter to StockholdersGlobeNewswireGAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 1y agoBFRGBFRGWBullFrog AI Announces Appointment of Chief Financial OfficerGlobeNewswireGAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI SymposiumGlobeNewswireGAITHERSBURG, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence
- 2y agoBFRGBFRGWBullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 MillionGlobeNewswireGAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 MillionGlobeNewswireGAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John BaldoniGlobeNewswireGAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence
- 2y agoBFRGBFRGWBullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114GlobeNewswireThe study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCCThe findings suggest that targeting β2-spectrin
- 2y agoBFRGBFRGWBullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswireGAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the
- 2y agoBFRGBFRGWBullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug TargetsGlobeNewswireGAITHERSBURG, Md., July 25, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced significant
- 2y agoBFRGBFRGWJoin BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12GlobeNewswireGAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence
- 2y agoBFRGBFRGWBullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric DisordersGlobeNewswireGAITHERSBURG, Md., May 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug discovery company using artificial
- 2y agoBFRGBFRGWBullFrog AI's CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & ExpoGlobeNewswireGAITHERSBURG, Md., April 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber InstituteGlobeNewswireGAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific OfficerGlobeNewswireGAITHERSBURG, Md., Feb. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common StockGlobeNewswireGAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI)
- 2y agoBFRGBFRGWBullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChipGlobeNewswireGAITHERSBURG, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullFrog AI Announces Closing of $5.7 Million Public OfferingGlobeNewswireGAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial
- 2y agoBFRGBFRGWBullfrog AI Announces Pricing of $5.7 Million Public OfferingGlobeNewswireGAITHERSBURG, Md., Feb. 01, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial